Norway
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -2.92 M
|
Dec. 31, 2023 | USD 14.13 | 1.11% |
|
Norway |
|
2 |
USD -1.90 M
|
Dec. 31, 2023 | USD 0.23 | -0.24% |
|
Norway |
|
3 |
USD -1.89 M
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
|
4 |
USD -1.21 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
5 |
USD -440.51 K
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
6 |
USD -215.79 K
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
7 |
USD -119.27 K
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
8 |
USD -1.49 K
|
Dec. 31, 2024 | USD 0.19 | -0.80% |
|
Norway |
|
9 |
USD 0.00
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Healthcare company in Norway with the highest Capital Expenditure is Medistim ASA (Oslo Stock Exchange: MEDI.OL) at USD -2.92 M.
The Healthcare company in Norway with the lowest Capital Expenditure is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD 0.00.
The top 10 Healthcare companies in Norway by Capital Expenditure are Medistim ASA, Nykode Therapeutics AS, ArcticZymes Technologies ASA, Photocure ASA, Gentian Diagnostics ASA, Navamedic ASA, Lifecare AS, Ultimovacs ASA and BerGenBio ASA.
The bottom 10 Healthcare companies in Norway by Capital Expenditure are BerGenBio ASA, Ultimovacs ASA, Lifecare AS, Navamedic ASA, Gentian Diagnostics ASA, Photocure ASA, ArcticZymes Technologies ASA, Nykode Therapeutics AS and Medistim ASA.